Cybin and Clinilabs Granted Schedule I DEA License for CYB003 Phase 1/2a First-In-Human Clinical Trial - Financial Post

Submitted by Anonymous (not verified) on Wed, 08/17/2022 - 12:04

Cybin and Clinilabs Granted Schedule I DEA License for CYB003 Phase 1/2a First-In-Human Clinical Trial  Financial Post